Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

533 results about "Phthalimide" patented technology

Phthalimide is the organic compound with the formula C₆H₄(CO)₂NH. It is the imide derivative of phthalic anhydride. It is a sublimable white solid that is slightly soluble in water but more so upon addition of base. It is used as a precursor to other organic compounds as a masked source of ammonia.

Polythioetherimide and preparation method thereof

InactiveCN101531758AReduce manufacturing costReduce synthesis reactionFiberAdhesive
The invention relates to polythioetherimide and a preparation method thereof. The method is characterized by comprising the following steps: mono-substituted phthalic anhydride isomer with structural formula II is adopted as a reaction material to react with organic diamine NH2RNH2 with half mol equivalent weight at the temperature of about 100 DEG C to about 350 DEG C to generate binary-substituted phthalimide; then binary-substituted phthalimide and sulfur with about equimolar equivalent weight are subjected to coupling polymerization reaction at the temperature of about 60 DEG C to about 260 DEG C under the existence of reducing agent, catalyst and reaction auxiliary agent to generate polythioetherimide resin with structural formula I; and the molecular weight of the resin can be adjusted by end capping agent. The preparation method can greatly reduce the preparation cost and reaction steps, the whole process is more reasonable and practical, and the obtained resin has superior comprehensive properties such as good heat resistance, mechanical properties, melting processing property and the like, can be widely applied in the related fields such as high-temperature resistant engineering plastics, films, adhesives, enameled wires, foamed plastics, fiber, advanced composite materials and the like; in the structural formula II, A substituent is chlorine atom or nitro at 3-bit or 4-bit; and in the structural formula I, R is substituted or unsubstituted organic group.
Owner:NINGBO INST OF MATERIALS TECH & ENG CHINESE ACADEMY OF SCI +1

USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE

The present invention refers to the use of phthalimide and/or sulphonamide derivatives with nitric oxide donor properties, which have important activities in increasing the gamma-globin gene expression and anti-inflammatory and analgesic activities, effective in the treatment of hematologic diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide. More particularly, the present invention describes the use of such phthalimide and/or sulphonamide derivatives for the treatment of sickle-cell disease. The invention also has as a novel characteristic the disclosure of new functionalized phthalimide derivatives designed from the prototypes thalidomide and hydroxyurea, and designed rationally through the strategy of molecular hybridization for the treatment of said diseases. The invention still discloses a new method for obtaining a specific sulphonamide derivative which can be used in the preparation of a drug for the treatment of diseases which require reducing the levels of the TNF-α factor and an exogenous source of nitric oxide.
Owner:UNIV ESTADUAL DE CAMPINAS UNICAMP +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products